| Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia C Moran, R Azziz, N Weintrob, SF Witchel, V Rohmer, D Dewailly, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3451-3456, 2006 | 239 | 2006 |
| Effects of endocrine disruptors in the development of the female reproductive tract EMF Costa, PM Spritzer, A Hohl, TASS Bachega Arquivos Brasileiros de Endocrinologia & Metabologia 58 (2), 153-161, 2014 | 160 | 2014 |
| An update of genetic basis of PCOS pathogenesis RP Crespo, TASS Bachega, BB Mendonça, LG Gomes Archives of endocrinology and metabolism 62 (3), 352-361, 2018 | 151 | 2018 |
| Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency TASS Bachega, AEC Billerbeck, G Madureira, JAM Marcondes, ... The Journal of Clinical Endocrinology & Metabolism 83 (12), 4416-4419, 1998 | 142 | 1998 |
| Influence of different genotypes on 17‐hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21‐hydroxylase deficiency TASS Bachega, AEC Billerbeck, JAM Marcondes, G Madureira, ... Clinical Endocrinology 52 (5), 601-607, 2000 | 107 | 2000 |
| Disorders of sex development: effect of molecular diagnostics JC Achermann, S Domenice, TASS Bachega, MY Nishi, BB Mendonca Nature Reviews Endocrinology 11 (8), 478-488, 2015 | 102 | 2015 |
| Guidelines for the Development of Comprehensive Care Centers for Congenital Adrenal Hyperplasia: Guidance from the CARES Foundation Initiative RJ Auchus, SF Witchel, KR Leight, J Aisenberg, R Azziz, TA Bachega, ... Int J Pediatr Endocrinol 2010, 275213-275213, 2010 | 99 | 2010 |
| Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood PC White, TASS Bachega Seminars in reproductive medicine 30 (05), 400-409, 2012 | 92 | 2012 |
| Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 89-95, 2009 | 92 | 2009 |
| Quality of life of patients with 46, XX and 46, XY disorders of sex development RC Amaral, M Inacio, VN Brito, TASS Bachega, S Domenice, IJP Arnhold, ... Clinical endocrinology 82 (2), 159-164, 2015 | 77* | 2015 |
| Microconversion between CYP21A2 and CYP21A1P Promoter Regions Causes the Nonclassical Form of 21-Hydroxylase Deficiency RS Araújo, BB Mendonca, AS Barbosa, CJ Lin, JAM Marcondes, ... The Journal of Clinical Endocrinology & Metabolism 92 (10), 4028-4034, 2007 | 76 | 2007 |
| The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred: an estimate based on a public neonatal screening program in the state of Goiás E LEMOS SILVEIRA, E PEREIRA DOS SANTOS, TAS BACHEGA, ... Journal of pediatric endocrinology & metabolism 21 (5), 455-460, 2008 | 72 | 2008 |
| Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction DF de Carvalho, MC Miranda, LG Gomes, G Madureira, JAM Marcondes, ... European journal of endocrinology 175 (2), 107-116, 2016 | 70 | 2016 |
| Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due to a founder effect AEC Billerbeck, BB Mendonca, EM Pinto, G Madureira, IJP Arnhold, ... The Journal of Clinical Endocrinology & Metabolism 87 (9), 4314-4317, 2002 | 70 | 2002 |
| e Silva, FA (2006) Anatomical and functional outcomes of feminizing genitoplasty for ambiguous genitalia in patients with virilizing congenital adrenal hyperplasia MH Sircili, BB Mendonca, FT Denes, G Madureira, TA Bachega Clinics 61, 209-214, 0 | 66* | |
| Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations TASS Bachega, EML Brenlha, AEC Billerbeck, JAM Marcondes, ... The Journal of Clinical Endocrinology & Metabolism 87 (2), 786-790, 2002 | 60 | 2002 |
| The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency LG Gomes, N Huang, V Agrawal, BB Mendonca, TASS Bachega, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2913-2916, 2008 | 58 | 2008 |
| Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia G Hayashi, C Faure, MF Brondi, C Vallejos, D Soares, É Oliveira, VN Brito, ... Arquivos Brasileiros de Endocrinologia & Metabologia 55, 632-637, 2011 | 56 | 2011 |
| Classic congenital adrenal hyperplasia and its impact on reproduction LG Gomes, TASS Bachega, BB Mendonca Fertility and Sterility 111 (1), 7-12, 2019 | 51 | 2019 |
| A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency AEC Billerbeck, TASS Bachega, ET Frazzatto, MY Nishi, AC Goldberg, ... The Journal of Clinical Endocrinology & Metabolism 84 (8), 2870-2872, 1999 | 51 | 1999 |
